{"id":"W2063627867","doi":"10.1016/j.jaad.2007.09.010","title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":883,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Randomized controlled trial; Dermatology; Physical therapy; Internal medicine; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431842,0.002675269,0.005402266,0.0004582035,0.0008061719,0.001713285,0.001292606,0.002161944,0.007659015],"category_scores_gemma":[0.001821894,0.001039871,0.002624938,0.0005213957,0.001664323,0.001424301,0.0005238256,0.004013145,0.001544042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008420451,"about_ca_system_score_gemma":0.001203712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001266761,"about_ca_topic_score_gemma":0.002576887,"domain_scores_codex":[0.999127,0.0004178561,0.00005026235,0.000163159,0.00006973313,0.0001721342],"domain_scores_gemma":[0.9990461,0.0002935262,0.0001779766,0.00008705345,0.00006588936,0.000329455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9819236,0.00268614,0.0003636091,0.0008872365,0.001536583,0.00004177176,0.00004139419,0.0002163882,0.001353242,0.0001094554,0.001065493,0.00977507],"study_design_scores_gemma":[0.9886508,0.009636124,0.0006111157,0.00002439269,0.0004192858,0.00002049471,0.00001076186,0.0001217509,0.00007693101,0.00009146925,0.0003296304,0.000007193255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9530674,0.02508363,0.002305523,0.00265314,0.002355745,0.006859012,0.002348769,0.0004448993,0.004881801],"genre_scores_gemma":[0.9696732,0.008878431,0.003207203,0.003282015,0.001045544,0.005683529,0.001936548,0.0000629597,0.006230603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007659015,"threshold_uncertainty_score":0.02562195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02011710880311059,"score_gpt":0.3155302584066383,"score_spread":0.2954131496035277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}